# Regenaxis Therapeutics

> Restore Neurological Function

Business model and tags: Pharma & life sciences

## About Regenaxis Therapeutics

Developing therapies to regenerate myelin and restore function in central nervous system demyelinating diseases by targeting remyelination mechanisms.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Founded**: 2025
- **Revenue**: $2.3M – $17.9M (Tamtam estimate)
- **LinkedIn**: [linkedin.com/company/regenaxis-therapeutics](https://www.linkedin.com/company/regenaxis-therapeutics)

## Regenaxis Therapeutics at a glance

Regenaxis Therapeutics is a company in the Biotechnology Research industry.

Regenaxis Therapeutics was founded in 2025.

Regenaxis Therapeutics has 1–10 employees.

Regenaxis Therapeutics's revenue is $2.3M – $17.9M (Tamtam estimate).

## Frequently asked questions about Regenaxis Therapeutics

### What is Regenaxis Therapeutics's revenue?

Tamtam estimates Regenaxis Therapeutics's annual revenue at $2.3M – $17.9M.

### How many employees does Regenaxis Therapeutics have?

Regenaxis Therapeutics has 1–10 employees.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/regenaxis-therapeutics